• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基层医疗环境中非酒精性脂肪性肝病的临床队列

Clinical cohort of nonalcoholic fatty liver disease in a primary care setting.

作者信息

Gips Julia R, Yanek Lisa, Wu Jiajun, Hamilton James P, Woreta Tinsay A, Clark Jeanne M

机构信息

PGY-3 Osler Medical Residency, Johns Hopkins School of Medicine, Baltimore, USA.

Assistant Professor of General Internal Medicine, Johns Hopkins School of Medicine, Baltimore, USA.

出版信息

J Family Med Prim Care. 2024 Aug;13(8):2958-2963. doi: 10.4103/jfmpc.jfmpc_1769_23. Epub 2024 Jul 26.

DOI:10.4103/jfmpc.jfmpc_1769_23
PMID:39228565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11368356/
Abstract

BACKGROUND AND AIMS

Nonalcoholic fatty liver disease (NAFLD) is increasingly common, and primary care physicians (PCPs) are often the first to diagnose NAFLD. While guidelines on NAFLD management in primary care exist, there are limited data on clinical practice patterns.

APPROACH

We gathered data from over 370,000 patients with at least one PCP visit between July 2016 and September 2023. Using ICD-10 codes to identify patients with a diagnosis of NAFLD or Nonalcoholic Steatohepatitis (NASH), we extracted demographics, comorbidities, laboratory results, prescriptions, imaging orders, and referrals to describe their care.

RESULTS

We identified 10,334 patients with a diagnosis code of NAFLD (93.1%) and/or NASH (16.7%) during a PCP visit. Just over half (54.8%) were female, mean age was 52.8 years, and mean BMI was 33.2 kg/m with 90% having overweight or obese. More than 50% had hypertension and hyperlipidemia, and 38% had diabetes. At the diagnosis visit, 2.7% had ultrasound elastography ordered, 2.7% liver biopsy, and less than 1% magnetic resonance elastography. During follow-up ranging from 0 to 7 years, patients had a mean of 15 encounters, during which 4% were diagnosed with fibrosis or cirrhosis. Only 24.2% of patients were referred to a nutritionist and 18% had an appointment, and only 0.7% were referred to hepatology and 3.8% saw a hepatologist.

CONCLUSION

PCPs have not widely implemented clinical practice guidelines for NAFLD, resulting in suboptimal care including for the substantial minority with fibrosis or cirrhosis. Patients might benefit from targeted NAFLD education for PCPs and improved decision and management support.

摘要

背景与目的

非酒精性脂肪性肝病(NAFLD)日益常见,基层医疗医生(PCP)往往是最先诊断出NAFLD的人。虽然存在基层医疗中NAFLD管理的指南,但关于临床实践模式的数据有限。

方法

我们收集了2016年7月至2023年9月期间至少有一次基层医疗就诊的37万多名患者的数据。使用国际疾病分类第十版(ICD - 10)编码来识别诊断为NAFLD或非酒精性脂肪性肝炎(NASH)的患者,我们提取了人口统计学信息、合并症、实验室检查结果、处方、影像学检查医嘱和转诊信息来描述他们的治疗情况。

结果

我们在基层医疗就诊期间识别出10334例诊断编码为NAFLD(93.1%)和/或NASH(16.7%)的患者。略超过一半(54.8%)为女性,平均年龄为52.8岁,平均体重指数为33.2kg/m²,90%超重或肥胖。超过50%患有高血压和高脂血症,38%患有糖尿病。在诊断就诊时,2.7%接受了超声弹性成像检查,2.7%接受了肝活检,不到1%接受了磁共振弹性成像检查。在0至7年的随访期间,患者平均就诊15次,在此期间4%被诊断为纤维化或肝硬化。只有24.2%的患者被转诊至营养师处,其中18%预约就诊,只有0.7%被转诊至肝病科,3.8%看过肝病专家。

结论

基层医疗医生尚未广泛实施NAFLD的临床实践指南,导致治疗效果欠佳,包括对相当一部分患有纤维化或肝硬化的患者。患者可能会从针对基层医疗医生的针对性NAFLD教育以及改善决策和管理支持中受益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ea9/11368356/494d77df6d91/JFMPC-13-2958-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ea9/11368356/95baf0ce6a02/JFMPC-13-2958-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ea9/11368356/494d77df6d91/JFMPC-13-2958-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ea9/11368356/95baf0ce6a02/JFMPC-13-2958-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ea9/11368356/494d77df6d91/JFMPC-13-2958-g002.jpg

相似文献

1
Clinical cohort of nonalcoholic fatty liver disease in a primary care setting.基层医疗环境中非酒精性脂肪性肝病的临床队列
J Family Med Prim Care. 2024 Aug;13(8):2958-2963. doi: 10.4103/jfmpc.jfmpc_1769_23. Epub 2024 Jul 26.
2
Nonalcoholic steatohepatitis diagnosis and treatment from the perspective of patients and primary care physicians: a cross-sectional survey.非酒精性脂肪性肝炎的诊断和治疗:从患者和初级保健医生的角度进行的横断面调查。
Ann Med. 2023 Dec;55(1):2211349. doi: 10.1080/07853890.2023.2211349.
3
Clinical characteristics and management of patients with nonalcoholic steatohepatitis in a real-world setting: analysis of the Ipsos NASH therapy monitor database.真实世界环境中非酒精性脂肪性肝炎患者的临床特征和管理:对 Ipsos NASH 治疗监测数据库的分析。
BMC Gastroenterol. 2023 May 19;23(1):160. doi: 10.1186/s12876-023-02794-4.
4
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.瘦型非酒精性脂肪性肝病患者的肝脏和心血管损伤,及其与内脏肥胖的关系。
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1604-1611.e1. doi: 10.1016/j.cgh.2017.04.045. Epub 2017 May 26.
5
Identifying High-Risk Patients With Nonalcoholic Fatty Liver Disease: An Opportunity for Intervention Within the Primary Care Setting.识别非酒精性脂肪性肝病的高危患者:在初级保健环境中进行干预的机会。
J Clin Gastroenterol. 2023 Oct 1;57(9):956-961. doi: 10.1097/MCG.0000000000001784.
6
[An interpretation of the AASLD practice guideline on the diagnosis and management of nonalcoholic fatty liver disease in 2017].[2017年美国肝病研究学会非酒精性脂肪性肝病诊断和管理实践指南解读]
Zhonghua Gan Zang Bing Za Zhi. 2017 Sep 20;25(9):687-694. doi: 10.3760/cma.j.issn.1007-3418.2017.09.008.
7
Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications.当前和新兴的非酒精性脂肪性肝病生物标志物和影像学手段:临床和研究应用。
Clin Ther. 2021 Sep;43(9):1505-1522. doi: 10.1016/j.clinthera.2021.07.012. Epub 2021 Aug 13.
8
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.非酒精性脂肪性肝病、非酒精性脂肪性肝炎及相关纤维化的诊断方法。
Hepatology. 2018 Jul;68(1):349-360. doi: 10.1002/hep.29721.
9
Nonalcoholic Fatty Liver Disease: Interface Between Primary Care and Hepatology Clinics.非酒精性脂肪性肝病:基层医疗与肝病科诊所之间的联系
Hepatol Commun. 2020 Feb 20;4(4):518-526. doi: 10.1002/hep4.1486. eCollection 2020 Apr.
10
Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD.成人糖尿病和非酒精性脂肪性肝病患者非酒精性脂肪性肝炎和晚期肝纤维化的临床模型:非酒精性脂肪性肝病转诊指南
Diabetes Care. 2015 Jul;38(7):1347-55. doi: 10.2337/dc14-1239. Epub 2015 Apr 17.

本文引用的文献

1
Nonalcoholic steatohepatitis diagnosis and treatment from the perspective of patients and primary care physicians: a cross-sectional survey.非酒精性脂肪性肝炎的诊断和治疗:从患者和初级保健医生的角度进行的横断面调查。
Ann Med. 2023 Dec;55(1):2211349. doi: 10.1080/07853890.2023.2211349.
2
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.美国肝病研究学会非酒精性脂肪性肝病临床评估与管理实践指南
Hepatology. 2023 May 1;77(5):1797-1835. doi: 10.1097/HEP.0000000000000323. Epub 2023 Mar 17.
3
The diagnosis and management of nonalcoholic fatty liver disease: A patient-friendly summary of the 2018 AASLD guidelines.
非酒精性脂肪性肝病的诊断与管理:2018年美国肝病研究学会指南的患者友好型总结
Clin Liver Dis (Hoboken). 2022 Jul 1;19(6):222-226. doi: 10.1002/cld.1216. eCollection 2022 Jun.
4
Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017-2018 transient elastography data and application of machine learning.利用 2017-2018 年美国国家健康和营养调查瞬态弹性成像数据及机器学习预测非酒精性脂肪性肝病的流行率。
Hepatol Commun. 2022 Jul;6(7):1537-1548. doi: 10.1002/hep4.1935. Epub 2022 Apr 1.
5
Tagging incidental finding of fatty liver on ultrasound: A novel intervention to improve early detection of liver fibrosis.超声检查中标记脂肪肝的偶然发现:一种改善肝纤维化早期检测的新干预措施。
J Clin Transl Res. 2021 Sep 29;7(5):641-647. eCollection 2021 Oct 26.
6
Preparing for the NASH epidemic: A call to action.应对非酒精性脂肪性肝炎流行:行动呼吁。
Metabolism. 2021 Sep;122:154822. doi: 10.1016/j.metabol.2021.154822. Epub 2021 Jul 19.
7
Nonalcoholic Fatty Liver Disease and Recent Guideline Updates.非酒精性脂肪性肝病与近期指南更新
Clin Liver Dis (Hoboken). 2021 Feb 1;17(1):23-28. doi: 10.1002/cld.1045. eCollection 2021 Jan.
8
Fibrosis progression rate in a systematic review of placebo-treated nonalcoholic steatohepatitis.纤维化进展率在安慰剂治疗非酒精性脂肪性肝炎的系统评价中。
Liver Int. 2021 May;41(5):982-995. doi: 10.1111/liv.14749. Epub 2020 Dec 23.
9
Nonalcoholic Fatty Liver Disease and Diabetes: An Epidemiological Perspective.非酒精性脂肪性肝病与糖尿病:流行病学视角。
Endocrinol Metab (Seoul). 2019 Sep;34(3):226-233. doi: 10.3803/EnM.2019.34.3.226.
10
Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis.当前非酒精性脂肪性肝病管理指南:系统评价与比较分析。
World J Gastroenterol. 2018 Aug 14;24(30):3361-3373. doi: 10.3748/wjg.v24.i30.3361.